C136282Level 4
Bevacizumab/Cisplatin/Pemetrexed Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of bevacizumab, cisplatin and pemetrexed that is used for the treatment of non-small cell lung cancer (NSCLC).
**Synonyms:** - Avastin/Cisplatin/Pemetrexed - Bevacizumab-Cisplatin-Pemetrexed - Bevacizumab-Cisplatin-Pemetrexed Regimen - Bevacizumab/Cisplatin/Pemetrexed - Cisplatin, Pemetrexed, Bevacizumab - Cisplatin, Pemetrexed, Bevacizumab-adcd - Cisplatin, Pemetrexed, Bevacizumab-awwb - Cisplatin, Pemetrexed, Bevacizumab-aybi - Cisplatin, Pemetrexed, Bevacizumab-bvzr - Cisplatin, Pemetrexed, Bevacizumab-equi - Cisplatin, Pemetrexed, Bevacizumab-maly - Cisplatin, Pemetrexed, Bevacizumab-onbe
GET
/api/v1/systems/nci_thesaurus/nodes/C136282Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.